Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
To determine an optimal dose of AeroFact administered by nasal continuous positive airway pressure (nCPAP) versus stand of care in reducing the rate of intubation/cannulation and bolus surfactant instillation in the first 7 days after birth.
Clinical Research Coordinator: Janet Han - 510.204.1757 or e-mail: Janet.Han@sutterhealth.org
Principal Investigator
Related Studies
Hyper-localized Air Pollution Measures and Preterm Birth in the Bay Area
Investigators: External PI, Principal Investigator, Sylvia Sudat, PhD